Spots Global Cancer Trial Database for gadolinium
Every month we try and update this database with for gadolinium cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Correlation Between the Genetic and Neuroimaging Signatures in Newly Diagnosed Glioblastoma Patients Before Surgery | NCT02590497 | Glioblastoma | Diffusion Weigh... Gadolinium Laboratory Biom... Magnetic Resona... Magnetic Resona... Magnetic Resona... Perfusion Magne... | - | Ohio State University Comprehensive Cancer Center | |
Ferumoxytol in Improving MR Imaging in Patients With High-Grade Brain Tumors or Cerebral Metastases | NCT00103038 | Central Nervous... Malignant Gliom... Metastatic Mali... | 3 Tesla Magneti... Dynamic Contras... Dynamic Suscept... Ferumoxytol Gadolinium MRI-Based Angio... | 18 Years - | OHSU Knight Cancer Institute | |
Gadolinium and Ferumoxytol MRI in Diagnosing Patients With Abnormalities in the Central Nervous System | NCT03270059 | Central Nervous... Cranial Nerve D... Metastatic Mali... | Ferumoxytol Gadolinium Magnetic Resona... | 10 Years - | OHSU Knight Cancer Institute | |
SH L 562BB Phase II/III Dose Justification and Gadoteridol-controlled Comparative Study | NCT00522951 | Brain Metastase... | Gadobutrol (Gad... Gadobutrol (Gad... ProHance | 20 Years - | Bayer | |
Extent of Breast Cancer and the Role of Pre-Operative Sonography and MRI | NCT02587663 | Ductal Breast C... Stage IA Breast... Stage IB Breast... Stage II Breast... | Contrast-enhanc... Mammography Therapeutic Con... Ultrasonography Ultrasonography Gadolinium | 18 Years - | University of Southern California | |
Metabolic Characteristics of Brain Tumors Using Hyperpolarized Carbon-13 Magnetic Resonance Spectroscopic Imaging (MRSI) | NCT03067467 | Brain Tumor Adu... | Hyperpolarized ... Gadolinium | 18 Years - 70 Years | University of Texas Southwestern Medical Center | |
Effect on Body Movement and Mental Skills in Patients Who Received Gadolinium-based Contrast Media for Magnetic Resonance Examination Multiple Times Within 5 Years | NCT04373564 | Motor Function Cognitive Funct... Contrast Media | Motor Tests Cognitive Tests Unenhanced-MRI ... Gadolinium Meas... Gadoxetate diso... Gadobenate dime... Gadodiamide Gadoterate megl... Gadobutrol Gadoteridol | 18 Years - 64 Years | Guerbet | |
CytoreductiveSurgery & HIPEC w/Gemcitabine+Chemotherapy w/Dacarbazine in Uterine Leiomyosarcoma | NCT04727242 | LMS - Leiomyosa... Uterine Leiomyo... | Gemcitabine Dacarbazine Cytoreductive S... Functional Asse... Computed Tomogr... Gadolinium | 18 Years - | Stanford University | |
MRI Study With Ferumoxytol in Assessing Early Response in Patients With Glioblastoma Multiforme Receiving Temozolomide and Radiation Therapy | NCT00660543 | Adult Brain Gli... | Gadolinium Ferumoxytol Non... Dynamic Contras... Dynamic Suscept... Diffusion Weigh... MRI-Based Angio... | 18 Years - | OHSU Knight Cancer Institute | |
Ferumoxytol- and Gadolinium-Labeled MRI in Measuring Tumors Before or After Treatment in Patients With Primary or Metastatic Brain Tumors | NCT00659126 | Metastatic Mali... Primary Brain N... | 3 Tesla Magneti... Dynamic Contras... Dynamic Suscept... Ferumoxytol Gadolinium High Field Stre... Susceptibility ... | 18 Years - | OHSU Knight Cancer Institute | |
PET-MRI After Radiofrequency Ablation (RFA) or Microwave Ablation (MWA) | NCT01895673 | Liver Neoplasms Local Neoplasm ... | Gadolinium | 18 Years - | Amsterdam UMC, location VUmc | |
PET/MRI, 18F-FDG PET/CT and Whole Body MRI in Finding Extramedullary Myeloid Leukemia in Patients With Newly Diagnosed Acute Myeloid Leukemia | NCT02390635 | Acute Myeloid L... Acute Promyeloc... | Computed Tomogr... Diffusion Weigh... Fludeoxyglucose... Gadolinium Magnetic Resona... Positron Emissi... Three-Dimension... | 18 Years - | M.D. Anderson Cancer Center | |
CytoreductiveSurgery & HIPEC w/Gemcitabine+Chemotherapy w/Dacarbazine in Uterine Leiomyosarcoma | NCT04727242 | LMS - Leiomyosa... Uterine Leiomyo... | Gemcitabine Dacarbazine Cytoreductive S... Functional Asse... Computed Tomogr... Gadolinium | 18 Years - | Stanford University | |
Correlation Between the Genetic and Neuroimaging Signatures in Newly Diagnosed Glioblastoma Patients Before Surgery | NCT02590497 | Glioblastoma | Diffusion Weigh... Gadolinium Laboratory Biom... Magnetic Resona... Magnetic Resona... Magnetic Resona... Perfusion Magne... | - | Ohio State University Comprehensive Cancer Center | |
Ferumoxytol in Improving MR Imaging in Patients With High-Grade Brain Tumors or Cerebral Metastases | NCT00103038 | Central Nervous... Malignant Gliom... Metastatic Mali... | 3 Tesla Magneti... Dynamic Contras... Dynamic Suscept... Ferumoxytol Gadolinium MRI-Based Angio... | 18 Years - | OHSU Knight Cancer Institute | |
PET/MRI, 18F-FDG PET/CT and Whole Body MRI in Finding Extramedullary Myeloid Leukemia in Patients With Newly Diagnosed Acute Myeloid Leukemia | NCT02390635 | Acute Myeloid L... Acute Promyeloc... | Computed Tomogr... Diffusion Weigh... Fludeoxyglucose... Gadolinium Magnetic Resona... Positron Emissi... Three-Dimension... | 18 Years - | M.D. Anderson Cancer Center | |
PET/MRI, 18F-FDG PET/CT and Whole Body MRI in Finding Extramedullary Myeloid Leukemia in Patients With Newly Diagnosed Acute Myeloid Leukemia | NCT02390635 | Acute Myeloid L... Acute Promyeloc... | Computed Tomogr... Diffusion Weigh... Fludeoxyglucose... Gadolinium Magnetic Resona... Positron Emissi... Three-Dimension... | 18 Years - | M.D. Anderson Cancer Center | |
Hyperpolarized Carbon C 13 Pyruvate Magnetic Resonance Spectroscopic Imaging in Detecting Lactate and Bicarbonate in Participants With Central Nervous System Tumors | NCT03565367 | Malignant Centr... Metastatic Mali... | Gadolinium Hyperpolarized ... Magnetic Resona... Magnetic Resona... | 18 Years - | Stanford University | |
DSC-MRI With Ferumoxytol and DCE-MRI With Gadolinium in Imaging Vascular Properties in Younger Patients With Brain Tumors | NCT00978562 | Childhood Brain... Recurrent Child... | Dynamic Contras... Dynamic Suscept... Ferumoxytol Non... Gadolinium | 5 Years - 18 Years | OHSU Knight Cancer Institute | |
Chronic Convection Enhanced Delivery of Topotecan | NCT03154996 | Gliomas | Topotecan Gadolinium Synchromed II i... | 18 Years - | Columbia University | |
Ferumoxytol in Improving MR Imaging in Patients With High-Grade Brain Tumors or Cerebral Metastases | NCT00103038 | Central Nervous... Malignant Gliom... Metastatic Mali... | 3 Tesla Magneti... Dynamic Contras... Dynamic Suscept... Ferumoxytol Gadolinium MRI-Based Angio... | 18 Years - | OHSU Knight Cancer Institute | |
Metabolic Characteristics of Brain Tumors Using Hyperpolarized Carbon-13 Magnetic Resonance Spectroscopic Imaging (MRSI) | NCT03067467 | Brain Tumor Adu... | Hyperpolarized ... Gadolinium | 18 Years - 70 Years | University of Texas Southwestern Medical Center | |
SH L 562BB Phase II/III Dose Justification and Gadoteridol-controlled Comparative Study | NCT00522951 | Brain Metastase... | Gadobutrol (Gad... Gadobutrol (Gad... ProHance | 20 Years - | Bayer | |
Study of Tumor Treating Fields With Hypofractionated Chemoradiotherapy in Newly Diagnosed Glioblastoma | NCT04474353 | Glioblastoma Newly Diagnosed... | Optune Gadolinium Temozolomide Stereotactic ra... | 18 Years - | Stanford University | |
MRI Study With Ferumoxytol in Assessing Early Response in Patients With Glioblastoma Multiforme Receiving Temozolomide and Radiation Therapy | NCT00660543 | Adult Brain Gli... | Gadolinium Ferumoxytol Non... Dynamic Contras... Dynamic Suscept... Diffusion Weigh... MRI-Based Angio... | 18 Years - | OHSU Knight Cancer Institute |